CQENS Technologies Inc. financial data

Industry
Pharmaceutical Preparations
Location
5550 Nicollet Avenue, Minneapolis, MN
State of incorporation
DE
Fiscal year end
December 31
Former names
VapAria Corp (to 12/18/2019), OICco ACQUISITION IV, INC. (to 8/12/2014)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 127 % +147%
Debt-to-equity 72.3 % -13.5%
Return On Equity -358 % +27.9%
Return On Assets -208 % +23.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.7M shares +2.16%
Common Stock, Shares, Outstanding 26.7M shares +1.98%
Entity Public Float 0 USD
Common Stock, Value, Issued 2.67K USD +2.03%
Weighted Average Number of Shares Outstanding, Basic 26.6M shares +1.6%
Weighted Average Number of Shares Outstanding, Diluted 26.6M shares +1.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.33M USD +0.65%
General and Administrative Expense 1.21M USD -49.2%
Operating Income (Loss) -8.61M USD -465%
Net Income (Loss) Attributable to Parent -8.6M USD -38.6%
Earnings Per Share, Basic 0.01 USD/shares -95.8%
Earnings Per Share, Diluted 0.01 USD/shares -425%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.77M USD +317%
Assets, Current 3.99M USD +296%
Property, Plant and Equipment, Net 142K USD -12.4%
Operating Lease, Right-of-Use Asset 38.2K USD -59.4%
Intangible Assets, Net (Excluding Goodwill) 1.29M USD +14.5%
Assets 5.98M USD +110%
Accounts Payable, Current 126K USD -6.58%
Accrued Liabilities, Current 353K USD +25.9%
Liabilities, Current 1.83M USD +33.5%
Operating Lease, Liability, Noncurrent 4.03K USD -92.8%
Liabilities 1.83M USD +30.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -34 USD
Retained Earnings (Accumulated Deficit) -31.5M USD -37.7%
Stockholders' Equity Attributable to Parent 4.15M USD +187%
Liabilities and Equity 5.98M USD +110%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -350K USD +49.5%
Net Cash Provided by (Used in) Financing Activities 415K USD -34.1%
Net Cash Provided by (Used in) Investing Activities -64.5K USD -12.2%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 26.7M shares +1.98%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -121K USD +87.9%
Deferred Tax Assets, Valuation Allowance 374K USD +22.2%
Operating Lease, Liability 38.2K USD -59.4%
Depreciation 5.04K USD 0%
Payments to Acquire Property, Plant, and Equipment 7.8K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -5.71M USD -464%
Lessee, Operating Lease, Liability, to be Paid 38.9K USD -60.5%
Operating Lease, Liability, Current 38.2K USD -34.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.7K USD -64.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.2K USD -64.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 672 USD -83.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.2K USD
Deferred Tax Assets, Operating Loss Carryforwards 374K USD +22.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Operating Lease, Payments 66.7K USD
Additional Paid in Capital 35.6M USD +46.6%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%